Palantir’s multi-decade prowess in advanced mission-critical analytics is already making its AI genuinely valuable. Read why ...

Chances are high that the Bitcoin dominance has either already peaked for this cycle or will peak in November or December ...

YieldMax TSLA Option Income Strategy ETF has historically underperformed, but recent political developments involving Elon ...

Microsoft's $13 billion partnership with OpenAI underscores its ambitious AI strategy. Click here to read why MSFT stock is a ...

David Abrams’ 13F portfolio value increased from $5.11B to $6.23B in Q3 2024, with the top three stakes comprising ~66%. The ...

I reiterate a 'Buy' rating for Zoetis with a one-year target price of $210 per share, driven by strong product performance ...

Analysis of the potential impact of Trump's policies on growth and the stock market, including tariffs, tax cuts, and ...

Global Medical REIT's Q3-2024 results show flat rental revenue and AFFO. Check out a few concerns with GMRE stock and why it ...

Target Resources cut its dividend in 2020 to repay debt faster, reflecting its aggressive growth strategy. See why TRGP stock ...

Booz Allen Hamilton anticipates significant growth in its cybersecurity business. Read why I reiterate a Strong Buy rating ...

The acquisition reshapes FREYR Battery into a profitable growth company while providing immediate revenue streams. See why ...

SPDR S&P Insurance ETF's equal-weighted approach and high volume mitigate single-stock risk. Find out why KIE is a Buy.